RECTOVAGINAL SEPTUM ABSCESS

This adverse event was reported 22 times

These drugs are most commonly taken by patients reporting RECTOVAGINAL SEPTUM ABSCESS:

# Drug Count
0 ADALIMUMAB 13
1 INFLIXIMAB 8
2 USTEKINUMAB 8
3 AZATHIOPRINE 7
4 ADALIMUMAB-AATY 6
5 ADALIMUMAB-ADAZ 6
6 ADALIMUMAB-FKJP 6
7 MERCAPTOPURINE 6
8 SULFASALAZINE 6
9 CERTOLIZUMAB PEGOL 1
See all common drugs associated with RECTOVAGINAL SEPTUM ABSCESS

RECTOVAGINAL SEPTUM ABSCESS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PURIXAN 1 0.0013
1 MERCAPTOPURINE 6 0.0003
2 ADALIMUMAB-FKJP 6 0.0001
3 ADALIMUMAB-AATY 6 0.0001
4 ADALIMUMAB-ADAZ 6 0.0001
5 SULFASALAZINE 6 0.0001
6 AZATHIOPRINE 7 0.0001
7 USTEKINUMAB 8 0.0001
8 INFLIXIMAB 8 0.0000
9 METRONIDAZOLE TOPICAL 1 0.0000
See all drugs enriched for association with RECTOVAGINAL SEPTUM ABSCESS

RECTOVAGINAL SEPTUM ABSCESS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-12 Antagonist [EPC] 8 0.0001
1 Interleukin-23 Antagonist [EPC] 8 0.0001
2 Purine Antimetabolite [EPC] 7 0.0001
3 Aminosalicylate [EPC] 6 0.0001
4 Nitroimidazole Antimicrobial [EPC] 1 0.0000
5 Integrin Receptor Antagonist [EPC] 1 0.0000
6 Tumor Necrosis Factor Blocker [EPC] 9 0.0000
7 Retinoid [EPC] 1 0.0000
See all drug classes enriched for association with RECTOVAGINAL SEPTUM ABSCESS